Acusphere
Speciality pharmaceutical company developing cardiovascular drugs for the detection of coronary artery disease.
Launch date
Employees
Market cap
AUD5.4m
Enterprise valuation
AUD5m (Public information from Sep 2024)
Share price
$0.00001 ACUS
Lexington Kentucky (HQ)
Authorizing premium user...